ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 164 filers reported holding ANIKA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $491,000 | -11.1% | 22,000 | 0.0% | 0.10% | +9.5% |
Q1 2022 | $552,000 | -29.9% | 22,000 | 0.0% | 0.10% | -15.9% |
Q4 2021 | $788,000 | -15.8% | 22,000 | 0.0% | 0.11% | -16.9% |
Q3 2021 | $936,000 | -1.7% | 22,000 | 0.0% | 0.14% | +7.1% |
Q2 2021 | $952,000 | +6.1% | 22,000 | 0.0% | 0.13% | 0.0% |
Q1 2021 | $897,000 | -9.9% | 22,000 | 0.0% | 0.13% | -9.3% |
Q4 2020 | $996,000 | +27.9% | 22,000 | 0.0% | 0.14% | +4.5% |
Q3 2020 | $779,000 | -6.1% | 22,000 | 0.0% | 0.13% | +0.8% |
Q2 2020 | $830,000 | +79.3% | 22,000 | +37.5% | 0.13% | +77.3% |
Q1 2020 | $463,000 | +78.8% | 16,000 | +220.0% | 0.08% | +188.5% |
Q4 2019 | $259,000 | -52.8% | 5,000 | -50.0% | 0.03% | -53.6% |
Q3 2019 | $549,000 | -66.2% | 10,000 | -75.0% | 0.06% | -64.6% |
Q2 2019 | $1,625,000 | +34.3% | 40,000 | 0.0% | 0.16% | +31.7% |
Q1 2019 | $1,210,000 | -10.0% | 40,000 | 0.0% | 0.12% | -18.4% |
Q4 2018 | $1,344,000 | -3.4% | 40,000 | +21.2% | 0.15% | +20.5% |
Q3 2018 | $1,392,000 | +155.9% | 33,000 | +94.1% | 0.12% | +154.2% |
Q2 2018 | $544,000 | – | 17,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |